TACSTD2 and endometrial cancer: Supplementary Figure S1 shows representative flow cytometric analysis of END(K)254 and END(K)265 cell lines, both showing high TROP2 expression, and END(K)34, a primary endometrial cancer cell line showing no TROP2 expression.